{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:22:18Z","timestamp":1791490938824,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40263-018-0600-y","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T09:41:35Z","timestamp":1547026895000},"page":"187-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intravenous Corticosteroids as an Adjunctive Treatment for Refractory and Super-Refractory Status Epilepticus: An Observational Cohort Study"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2632-5236","authenticated-orcid":false,"given":"Vasiliki","family":"Pantazou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Novy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"600_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrneurol.2013.154","volume":"9","author":"R Sutter","year":"2013","unstructured":"Sutter R, Kaplan PW, R\u00fcegg S. Outcome predictors for status epilepticus\u2014what really counts. Nat Rev Neurol. 2013;9:525.","journal-title":"Nat Rev Neurol."},{"key":"600_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ane.12605","volume":"135","author":"L Delaj","year":"2016","unstructured":"Delaj L, Novy J, Ryvlin P, Marchi NA, Rossetti AO. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study. Acta Neurol Scand. 2016;135:92\u20139.","journal-title":"Acta Neurol Scand"},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","volume":"134","author":"S Shorvon","year":"2011","unstructured":"Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802\u201318.","journal-title":"Brain"},{"key":"600_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48\u201361.","journal-title":"Epilepsy Curr."},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","volume":"136","author":"SR Irani","year":"2013","unstructured":"Irani SR, Stagg CJ, Schott JM, Rosenthal CR, Schneider SA, Pettingill P, et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain. 2013;136:3151\u201362.","journal-title":"Brain"},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1212\/WNL.0000000000001717","volume":"85","author":"M Spatola","year":"2015","unstructured":"Spatola M, Novy J, Du Pasquier R, Dalmau J, Rossetti AO. Status epilepticus of inflammatory etiology: a cohort study. Neurology. 2015;85:464\u201370.","journal-title":"Neurology."},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1586\/14737175.2015.1079130","volume":"15","author":"A Vezzani","year":"2015","unstructured":"Vezzani A, Dingledine R, Rossetti AO. Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother. 2015;15:1081\u201392.","journal-title":"Expert Rev Neurother"},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ejpn.2015.04.006","volume":"19","author":"DP Bakker","year":"2015","unstructured":"Bakker DP, Catsman-Berrevoets CE, Neuteboom RF. Effectiveness of a hybrid corticosteroid treatment regimen on refractory childhood seizures and a review of other corticosteroid treatments. Eur J Paediatr Neurol. 2015;19:553\u201360.","journal-title":"Eur J Paediatr Neurol."},{"issue":"6","key":"600_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-0030-1249653","volume":"40","author":"RA Sevilla-Castillo","year":"2009","unstructured":"Sevilla-Castillo RA, Palacios GC, Ramirez-Campos J, Mora-Puga M, Diaz-Bustos R. Methylprednisolone for the treatment of children with refractory epilepsy. Neuropediatrics. 2009;40(6):265\u20138.","journal-title":"Neuropediatrics"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"e18200","DOI":"10.1371\/journal.pone.0018200","volume":"6","author":"N Marchi","year":"2011","unstructured":"Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. Deli M, editor. PLoS One. 2011;6:e18200.","journal-title":"PLoS One"},{"key":"600_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","volume":"51","author":"J Novy","year":"2010","unstructured":"Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51:251\u20136.","journal-title":"Epilepsia."},{"key":"600_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","volume":"255","author":"AO Rossetti","year":"2008","unstructured":"Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status Epilepticus Severity Score (STESS). J Neurol. 2008;255:1561\u20136.","journal-title":"J Neurol"},{"key":"600_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med. 1998;339:792\u20138.","journal-title":"N Engl J Med"},{"key":"600_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1528-1167.2011.03238.x","volume":"52","author":"S Shorvon","year":"2011","unstructured":"Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011;52:53\u20136.","journal-title":"Epilepsia."},{"key":"600_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/epi.12289","volume":"54","author":"MA Rogawski","year":"2013","unstructured":"Rogawski MA, Loya CM, Reddy K, Zolkowska D, Lossin C. Neuroactive corticosteroids for the treatment of status epilepticus. Epilepsia. 2013;54:93\u20138.","journal-title":"Epilepsia."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0600-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T19:13:26Z","timestamp":1578510806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0600-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0600-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"9 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Pantazou, Prof. Rossetti and Dr. Novy have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our SE registry is approved by the local ethics commission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}